The U.S. will send millions of doses of AstraZeneca's COVID-19 vaccine to Mexico and Canada, a White House official told The New York Times March 18.
Tens of millions of AstraZeneca vaccine doses have been purchased by the U.S. and are sitting in manufacturing facilities. The vaccine has been authorized for emergency use by dozens of countries, including Mexico and Canada, but the FDA has not cleared the candidate yet.
The U.S. will send 2.5 million doses to Mexico and 1.5 million to Canada, according to the Times.
More articles on pharmacy:
11 children’s hospitals, startup drugmaker partner to fight pediatric drug shortages
NYC pharmacist charged in $4M kickback, fraud scheme
CDC report: Vaccine administration in vulnerable communities needs improvement